@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns3:approve . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:09.997004"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" . rdf:OBJECT-POSITION rdfs:label "(73, 106)" . rdf:PREDICATE rdfs:label "approved" . rdf:PREDICATE-POSITION rdfs:label "112" . rdf:SUBJECT rdfs:label "Steroids ( Methylprednisolone or Dexamethasone ) and Tocilizumab ( TCZ ) , an interleukin-6 receptor antagonist" . rdf:SUBJECT-POSITION rdfs:label "(73, 106)" . rdf:Statement rdfs:label "Steroids (Methylprednisolone or Dexamethasone) and Tocilizumab (TCZ), an interleukin-6 receptor antagonist, are approved for the treatment of Cytokine release syndrome (CRS) or cytokine storm in India." . rdfs:ABSTRACT-UID ns2:50 "9wycjlj5" . rdfs:TRIPLE-UID ns1:9wycjlj5-TRIPLE-ABSTRACT-1 "9wycjlj5-TRIPLE-ABSTRACT-1" . rdfs:label "interleukin-6 receptor antagonist" . rdfs:label "cytokine release syndrome" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }